Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("PYRAZINAMIDE")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 366

  • Page / 15
Export

Selection :

  • and

Automated Chemiluminometric Screening of Counterfeit Drugs of the Antituberculosis Agent PyrazinamidePRIOR, Joao A. V; SANTOS, Joao L. M; LIMA, José L. F. C et al.Journal of AOAC International. 2009, Vol 92, Num 3, pp 830-836, issn 1060-3271, 7 p.Article

EFFECT OF PYRAZINAMIDE ON NICOTINAMIDE ADENINE DINUCLEOTIDE GLYCOHYDROLASE OF TUBERCULOUS HOSTTOIDA I.1973; AMER. REV. RESP. DIS.; U.S.A.; DA. 1973; VOL. 107; NO 4; PP. 648-655; BIBL. 21REF.Serial Issue

Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosisPIERRE-AUDIGIER, C; SURCOUF, C; CADET-DANIEL, V et al.The International journal of tuberculosis and lung disease. 2012, Vol 16, Num 2, pp 221-223, issn 1027-3719, 3 p.Article

Réaction cutanée après une prise de pyrazinamide = Cutaneous reaction after pyrazinamide initiationMULLIEZ, P; MBASSI FOUDA, F.-L; ROY SAINT-GEORGES, F et al.Médecine et maladies infectieuses. 2011, Vol 41, Num 9, pp 499-500, issn 0399-077X, 2 p.Article

Hepatotoxicity of Pyrazinamide : Cohort and Case-Control AnalysesCHANG, Kwok C; LEUNG, Chi C; YEW, Wing W et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 12, pp 1391-1396, issn 1073-449X, 6 p.Article

TUBERCULOSE PULMONAIRE RESISTANTE A LA STREPTOMYCINE + ISONIAZIDE ET TRAITEE PAR L'ASSOCIATION ETHIONAMIDE, PYRAZINAMIDE ET CYCLOSERINE. (A PROPOS DE 200 CAS)BARTAL M; NEJJAR A; LARAKI A et al.1973; TUNISIE MED.; TUNISIE; DA. 1973; NO 4; PP. 237-243; BIBL. 12REF.Article

SENSIBILITE DE BACILLES TUBERCULEUX A LA PYRAZINAMIDE DETERMINEE SUR LA BASE DE LEUR SENSIBILITE A LA NICOTINAMIDETATAR J.1974; GRUZLICA CHOR. PLUC; POLSKA; DA. 1974; VOL. 42; NO 8; PP. 765-771; ABS. RUSSE ANGL.; BIBL. 19REF.Article

TREATMENT OF RESISTANT PULMONARY TUBERCULOSIS IN HONG KONG WITH REGIMENS OF SECOND-LINE DRUGSHORSFALL PAL.1972; TUBERCLE; G.B.; DA. 1972; VOL. 53; NO 3; PP. 166-173; ABS. FR. ESP. ALLEM.; BIBL. 11REF.Serial Issue

IMPROVED METHOD FOR TESTING SUSCEPTIBILITY OF MYCOBACTERIUM TUBERCULOSIS TO PYRAZINAMIDEBUTLER WR; KILBURN JO.1982; JOURNAL OF CLINICAL MICROBIOLOGY; ISSN 0095-1137; USA; DA. 1982; VOL. 16; NO 6; PP. 1106-1109; BIBL. 14 REF.Article

AGRANULOCYTOSE ET DYSTROPHIE HEPATIQUE TOXIQUE AU COURS D'UN TRAITEMENT ANTITUBERCULEUXRABINA EH V; SAMICHASTNOVA AG; GOLUBYATNIKOVA GA et al.1972; ARKH. PATOL.; S.S.S.R.; DA. 1972; VOL. 34; NO 8; PP. 75-77; ABS. ANGL.; BIBL. 1/2 P.Serial Issue

EXACERBATION OF PORPHYRIA DURING TREATMENT OF PULMONARY TUBERCULOSISTREECE GL; MAGNUSSEN CR; PATTERSON JR et al.1976; AMER. REV. RESP. DIS.; U.S.A.; DA. 1976; VOL. 113; NO 2; PP. 233-237; BIBL. 15 REF.Article

FIRST-LINE CHEMOTHERAPY IN THE RETREATMENT OF BACTERIOLOGICAL RELAPSES OF PULMONARY TUBERCULOSIS FOLLOWING A SHORT-COURSE REGIMEN1976; LANCET; G.B.; DA. 1976; NO 7952; PP. 162-163; BIBL. 11 REF.Article

EFFICACITE THERAPEUTIQUE DE LA RIFAMPICINE DANS DES CAS RECIDIVANTS DE TUBERCULOSE PULMONAIRE. II. ETUDE DE L'ASSOCIATION RIFAMPICINE + ETHAMBUTOL + PYRAZINAMIDE, EN PARTICULIER EN TRAITEMENT INTERMITTENTRYOKEN.1972; KEKKAKU; JAP.; DA. 1972; VOL. 47; NO 12; PP. 457-466; ABS. ANGL.Article

Highly sensitive and selective determination of pyrazinamide at poly-L-methionine/reduced graphene oxide modified electrode by differential pulse voltammetry in human blood plasma and urine samplesCHEEMALAPATI, Srikanth; DEVADAS, Balamurugan; CHEN, Shen-Ming et al.Journal of colloid and interface science. 2014, Num 418, pp 132-139, issn 0021-9797, 8 p.Article

PYRAZINAMIDE PLASMA CONCENTRATIONS IN YOUNG CHILDREN WITH TUBERCULOSISMCILLERON, Helen; WILLEMSE, Marianne; SIMON SCHAAF, Hendrik et al.The Pediatric infectious disease journal. 2011, Vol 30, Num 3, pp 262-265, issn 0891-3668, 4 p.Article

Identification and characterization of Serratia marcescens ZJB-09104, a nitrile-converting bacteriumJIN, Li-Qun; LIU, Zhi-Qiang; ZHENG, Yu-Guo et al.World journal of microbiology & biotechnology. 2010, Vol 26, Num 5, pp 817-823, issn 0959-3993, 7 p.Article

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patientsWILKINS, Justin J; LANGDON, Grant; MCILLERON, Helen et al.European journal of clinical pharmacology. 2006, Vol 62, Num 9, pp 727-735, issn 0031-6970, 9 p.Article

Weekly rifapentine/lsoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contactsSCHECHTER, Mauro; ZAJDENVERG, Roberto; FALCO, Gisely et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 8, pp 922-926, issn 1073-449X, 5 p.Article

Estimation of antitubercular drugs combination in pharmaceutical formulations using multivariate calibrationMADAN, Jitender; DWIVEDI, A. K; SINGH, S et al.Analytica chimica acta. 2005, Vol 538, Num 1-2, pp 345-353, issn 0003-2670, 9 p.Article

Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centreSHU, C.-C; LEE, C.-H; LEE, M.-C et al.The International journal of tuberculosis and lung disease. 2013, Vol 17, Num 7, pp 934-939, issn 1027-3719, 6 p.Article

Pyrazinamide-Induced Anaphylaxis: Diagnosed by Skin Test and Successful DesensitizationBAVBEK, Sevim; YILIMAZ, Insu; AYDIN, Ömür et al.International archives of allergy and immunology. 2012, Vol 157, Num 2, pp 209-212, issn 1018-2438, 4 p.Article

Drug-drug interaction studies on first-line anti-tuberculosis drugsBHUTANI, Hemant; SINGH, Saranjit; JINDAL, K. C et al.Pharmaceutical development and technology. 2005, Vol 10, Num 4, pp 517-524, issn 1083-7450, 8 p.Article

Molecularly imprinted polymer for pyrazinamideBAO WEI SUN; YUAN ZONG LI; WEN BAO CHANG et al.Analytical letters. 2003, Vol 36, Num 8, pp 1501-1509, issn 0003-2719, 9 p.Article

The curious characteristics of pyrazinamide: a reviewZHANG, Y; MITCHISON, D.International journal of tuberculosis and lung disease. 2003, Vol 7, Num 1, pp 6-21, issn 1027-3719, 16 p.Article

Un effet immuno-allergique rare et grave du traitement antituberculeux: la neutropénie au pyrazinamide = Pyrazinamide-induced neutropenia: One new caseMOUBACHIR, H; ID AHMED, I; BOURKADI, J. E et al.Revue française d'allergologie (Amsterdam. Print). 2013, Vol 53, Num 6, pp 533-536, issn 1877-0312, 4 p.Article

  • Page / 15